Pfizer Inc. (NYSE:PFE – Get Free Report)’s share price fell 0.8% during trading on Thursday after UBS Group lowered their price target on the stock from $31.00 to $29.00. UBS Group currently has a ...

At the same time, the expiration of key patents is coming up for some major Pfizer drugs, including blood thinner Eliquis and ...

Wall Street analysts reasoned out why Pfizer (NYSE:PFE) shares could be under pressure on Tuesday even as the New York-based ...

PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...

With a market cap of $144.8 billion, New York-based Pfizer ... Despite PFE’s weak price action, analysts are moderately optimistic about its prospects. The stock has a consensus rating of ...

Pfizer on Thursday said it will raise its quarterly dividend by 2.4%. The New York-based drug company on Thursday said its board increased its cash dividend to 43 cents a share from 42 cents.

Range Financial Group LLC purchased a new stake in Pfizer Inc. (NYSE:PFE – Free Report) during the fourth quarter, according ...

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

Taking full advantage of the stock market and investing with confidence ... favorable times to buy high-momentum stocks. New York-based Pfizer markets a wide range of drugs and vaccines.

Pfizer Inc. closed $4.65 short of its 52-week high ($31.54), which the company reached on July 30th.

The stock has lost 12% this year through Monday. Starboard Value's Chief Executive Jeff Smith has publicly accused Pfizer of squandering its Covid successes and has suggested that CEO Albert ...